BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22101967)

  • 1. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.
    El-Hammadi M; Awad N
    AAPS PharmSciTech; 2012 Mar; 13(1):53-8. PubMed ID: 22101967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
    Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
    Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties.
    Javadzadeh Y; Siahi MR; Asnaashari S; Nokhodchi A
    Acta Pharm; 2007 Mar; 57(1):99-109. PubMed ID: 19839410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
    Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquisolid systems to improve the dissolution of furosemide.
    Akinlade B; Elkordy AA; Essa EA; Elhagar S
    Sci Pharm; 2010; 78(2):325-44. PubMed ID: 21179350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and evaluation of liquisolid compacts of diclofenac sodium.
    Kulkarni AS; Gaja JB
    PDA J Pharm Sci Technol; 2010; 64(3):222-32. PubMed ID: 21502022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts.
    Javadzadeh Y; Shariati H; Movahhed-Danesh E; Nokhodchi A
    Drug Dev Ind Pharm; 2009 Feb; 35(2):243-51. PubMed ID: 18785038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of dissolution rate of indomethacin: using liquisolid compacts.
    Saeedi M; Akbari J; Morteza-Semnani K; Enayati-Fard R; Sar-Reshteh-Dar S; Soleymani A
    Iran J Pharm Res; 2011; 10(1):25-34. PubMed ID: 24363677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S; Sadu S; Grover R
    J Pharm Sci; 1998 Jul; 87(7):867-72. PubMed ID: 9649356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.
    Singh SK; Srinivasan KK; Gowthamarajan K; Prakash D; Gaikwad NB; Singare DS
    Drug Dev Ind Pharm; 2012 Aug; 38(8):961-70. PubMed ID: 22251080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.
    Naureen F; Shah Y; Shah SI; Abbas M; Rehman IU; Muhammad S; Hamdullah H; Goh KW; Khuda F; Khan A; Chan SY; Mushtaq M; Ming LC
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.
    Kamble PR; Shaikh KS; Chaudhari PD
    Adv Pharm Bull; 2014; 4(2):197-204. PubMed ID: 24511485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
    Spireas S; Wang T; Grover R
    Drug Dev Ind Pharm; 1999 Feb; 25(2):163-8. PubMed ID: 10065349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.
    Patel DS; Pipaliya RM; Surti N
    Indian J Pharm Sci; 2015; 77(3):290-8. PubMed ID: 26180274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of Curcuma comosa tablets using liquisolid techniques: In vitro and in vivo evaluation.
    Jaipakdee N; Limpongsa E; Sripanidkulchai BO; Piyachaturawat P
    Int J Pharm; 2018 Dec; 553(1-2):157-168. PubMed ID: 30316793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of liquisolid compacts for olmesartan medoxomil.
    Prajapati ST; Bulchandani HH; Patel DM; Dumaniya SK; Patel CN
    J Drug Deliv; 2013; 2013():870579. PubMed ID: 24232077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.